Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003143029 | SCV003822255 | uncertain significance | not provided | 2019-06-28 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003150586 | SCV003838524 | uncertain significance | Cardiomyopathy | 2021-06-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004736313 | SCV005350876 | uncertain significance | TTN-related disorder | 2024-08-14 | no assertion criteria provided | clinical testing | The TTN c.88226G>A variant is predicted to result in the amino acid substitution p.Arg29409His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0052% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |